Victoza Novo Nordisk

Code: EU21239
€216.00
In Stock
Certified products
Certified products
We only sell certified products from the world's most famous brands!
Convenient payment
Convenient payment
You can transfer funds to a bank account or a USDT crypto wallet.
Fast delivery
Fast delivery
We will deliver your order within a few days.
Description Victoza Novo Nordisk
Specification Victoza Novo Nordisk
Features
Active Half-Life
Peptide
Active substance
Liraglutide
Also known as
NN2211
Blood pressure
May help reduce blood pressure in patients with type 2 diabetes
Chemical name
Liraglutide
Dosage
0.6-1.8 mg/day
Dosage (medical)
Typically initiated at 0.6 mg per day, titrated up to 1.2 mg or 1.8 mg depending on the patient's response and tolerability
Dosage (sports)
Not applicable
Effects
Improves glycemic control in type 2 diabetes, promotes weight loss
FORM
1 pen x 3 ml
Formula
C172H265N43O51
Half-life
Approximately 13 hours
Hepatotoxicity
Low
Lab Test
Monitoring of blood glucose and hemoglobin A1c levels
Main action
Lowers blood glucose levels
Side effects
Nausea, diarrhea, vomiting, constipation, reduced appetite, risk of pancreatitis
Storage conditions
Store in a refrigerator (2В°C to 8В°C), protect from light, do not freeze
Substance class
Glucagon-like peptide-1 (GLP-1) receptor agonist
Trade name
Victoza, Saxenda
Use in sports
Not typically used for performance enhancement
Water Retention
Minimal
Manufacturer
Novo Nordisk
Reviews
Average rating
0
Reviews (0)
5
0
4
0
3
0
2
0
1
0